))
E152 - Therapeutic Guidelines Diabetes
Manage episode 407081015 series 3557583
Content provided by Australian Prescriber. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Prescriber or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.
163 episodes
Share
